India, May 15 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.
Published by HT Digital Content Services with permission from Pivotal Sources....